E.g., 10/02/2022
E.g., 10/02/2022
Title Category Credit Event date Price
Big Data and 'Omics' Analysis in Urology (2020) $149.00 This course provides participants with an introduction to systems biology along with insights into the methods used to generate large datasets using ‘omics’ technologies, and the bioinformatics tools required for analysis. Despite the power of genomic, transcriptomic, and proteomic technologies, most researchers do not have the necessary computational expertise to analyze or interpret high content datasets unaided. Furthermore, many investigators are unaware of the unique challenges involved in experimental design as it pertains to systems-wide analyses.
Bladder Cancer Treatment Dilemmas: The Cases You Face and What To Do about Them Webcast (2022)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Update recent AUA, European Association of Urology (EAU), and National Comprehensive Cancer Network (NCCN®) Guidelines® for the quickly evolving field of bladder cancer. Case scenarios will outline important changes as well as concepts essential in providing evidence-based care.ACKNOWLEDGEMENTSSupport provided by independent educational grants from:AstraZenecaBristol Myers SquibbMerck & Co., Inc.Pfizer, Inc.
Building a Primary Palliative Care Model for Urology Webcast (2021)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Building a Primary Palliative Care Model for Urology Webcast (2021) discusses aspects of palliative care that benefit patients, the urologist’s role and their collaboration with palliative care clinicians including:
Case-Based Discussion: BCR and Novel Pet Imaging & M0 CRPC Podcast (2021)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 As a direct result of the significant increase in multiple FDA-approved therapeutic agents for use in patients with advanced prostate cancer, clinicians are challenged with a multitude of treatment options and potential sequencing of these agents that, consequently, make clinical decision-making more complex. This activity will build upon the newly updated 2020 AUA Guidelines on Metastatic Hormone Sensitive Prostate Cancer (HSPC) and Castration-Resistant Prostate Cancer (CRPC).
Case-Based Discussion: Early M1 CRPC and Advanced M1 CRPC Podcast (2021)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 As a direct result of the significant increase in multiple FDA-approved therapeutic agents for use in patients with advanced prostate cancer, clinicians are challenged with a multitude of treatment options and potential sequencing of these agents that, consequently, make clinical decision-making more complex. This activity will build upon the newly updated 2020 AUA Guidelines on Metastatic Hormone Sensitive Prostate Cancer (HSPC) and Castration-Resistant Prostate Cancer (CRPC).
Case-Based Discussion: Role of Genetic Testing in Advanced M1 CRPC & M1 CRPC Post-Docetaxel, Neuroendocrine Cancer and End-of-Life Care Podcast (...
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 As a direct result of the significant increase in multiple FDA-approved therapeutic agents for use in patients with advanced prostate cancer, clinicians are challenged with a multitude of treatment options and potential sequencing of these agents that, consequently, make clinical decision-making more complex. This activity will build upon the newly updated 2020 AUA Guidelines on Metastatic Hormone Sensitive Prostate Cancer (HSPC) and Castration-Resistant Prostate Cancer (CRPC).
Clinical Cases in Urology: Diagnosis and Treatment of Early Stage Testicular Cancer (2019)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Member only benefit! AUA Guidelines provide a comprehensive and rigorous summary of evidence relating to a variety of disease conditions, providing an indispensable resource for urologic education. The Clinical Cases in Urology guideline-based case scenarios were designed to help maximize the impact of the guidelines. This case will focus on the AUA Guideline, Diagnosis and Treatment of Early Stage Testicular Cancer. 
Clinical Cases in Urology: Incontinence after Prostate Treatment (2019)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Member only benefit! AUA Guidelines provide a comprehensive and rigorous summary of evidence relating to a variety of disease conditions, providing an indispensable resource for urologic education. The The Clinical Cases in Urology guideline-based Case Scenarios were designed to help maximize the impact of the guidelines. This case will focus on the AUA/SUFU Guideline, Incontinence after Prostate Treatment.
Clinical Cases in Urology: Recurrent Uncomplicated Urinary Tract Infections in Women (2019)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Member only benefit! AUA Guidelines provide a comprehensive and rigorous summary of evidence relating to a variety of disease conditions, providing an indispensable resource for urologic education. The Clinical Cases in Urology guideline-based Case Scenarios were designed to help maximize the impact of the guidelines. This case will focus on the AUA/CUA/SUFU Guideline, Recurrent Uncomplicated Urinary Tract Infections in Women.
Clinical Problem Solving (CPS) Protocol: Shared Decision Making and Engaging Disparities in Prostate Cancer Care (2021)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Engaging Disparities in Prostate Cancer Care consists of multiple educational activities featuring a variety of formats for the urologic healthcare team to reinforce the essentials of SDM to better assist high-risk patients in regards to prostate cancer screening and treatment. A live webinar, Clinical Problem Solving (CPS) Protocol, and Podcast Series will enable participants to be better prepared to apply SDM in their practice.
Conflict of Interest Disclosures $0.00 The mission of the AUA Office of Education is to provide quality, evidence-based continuing medical education that is independent and free of commercial bias to enhance the clinical competence and performance of urologists and the urologic care team.
Contemporary Pharmacotherapy for OAB 2022: Monotherapy and Combined Pharmacotherapy to Optimize Treatment Webcast (2022)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Much has been written and debated about drug treatment of overactive bladder (OAB) over the past 2 decades. Nevertheless, the field continues to evolve. OAB pharmacotherapy remains an area of active investigation, and innovation.
Controversies, Confusion, and the Future of Urologic Post-Operative Opioid Prescribing Reduction Strategies (2022)
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 Non-Physician Participation
$0.00 This activity includes a multidisciplinary panel of experts discussing how urologists can reduce opioid prescribing, non-opioid multi-modal options, alternative therapies to pain management, managing opioid tolerant patients, and upcoming post-operative pain management opportunities. 
Cultural Barriers for Ethnic Minorities Podcast (2022)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 The American Urological Association (AUA) is proposing to create a series of educational activities that aim to address Diversity, Equity and Inclusion (DEI) in Urology. The AUA recognizes that the strength of any community is rooted in diversity and is committed to leading the way in advancing DEI within urology.Diversity, Equity and Inclusion (DEI) in Urology is comprised of multiple educational formats, including a live (in-person and virtual) course, on-demand webcast and AUAUniversity podcast series. 
Diagnosis and Management of Localized, Locally Advanced and Advanced Kidney Cancer Webcast (2022)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Kidney cancer is not a single disease; it is made up of several different types of cancer, each with a different histology, a different clinical course, responding differently to therapy and caused by different genes. After completing this course, attendees be able to describe the different types of kidney cancer and the genes that cause each. They will learn how to identify the different types of inherited versus sporadic forms of kidney cancer.

Pages